NPS (03006) S

NOVA PHARMA SOLUTIONS BERHAD Summary

0.230

0.000 (0.00%)

Leap Market : Pharmaceuticals
High 0.000
Low 0.000
Volume -
Volume (B/S) 35,500 / 1,500
Price Bid/Ask 0.150 / 0.230
   
52w 0.160 - 0.280
ROE 4.55
P/E 78
EPS 0.30
DPS 0.20
DY 0.87%
 
NTA 0.0660
P/B 3.48
RPS 7.07
PSR 3
Market Cap 34.3M
Shares (mil) 149.01
RSI(14) Neutral 58.2
Stochastic(14) Neutral 50.0
Average Volume 0
Relative Volume 0.0

EPS DPS NTA Revenue P/L Quarter Q Date Financial Year Announced QoQ% YoY% Report
0.09 0.000 0.0660 2.82m 133.00k 2 2020-12-31 31 Dec, 2020 2021-02-23 117% 67.3% View
-0.52 0.000 0.0650 1.41m -782.00k 1 2020-06-30 31 Dec, 2020 2020-08-07 295.5% 213.3% View
0.27 0.200 0.0700 3.12m 400.00k 2 2019-12-31 31 Dec, 2019 2020-02-21 42% 75.4% View
0.46 0.000 0.0700 3.17m 690.00k 1 2019-06-30 31 Dec, 2019 2019-08-07 57.5% 27.8% View
1.11 0.610 0.0700 5.03m 1.62m 2 2018-12-31 31 Dec, 2018 2019-02-21 200.7% 12% View
0.37 0.000 0.0600 2.87m 540.00k 1 2018-06-30 31 Dec, 2018 2018-08-07 62.8% 55% View
0.21 0.230 0.0500 3.67m 1.45m 2 2017-12-31 31 Dec, 2017 2018-02-28 0% 33.2% View

Financial Year Revenue ('000) Net ('000) EPS Report
31 Dec, 2020 4,235 -649 -0.43
31 Dec, 2019 6,295 1,090 0.73
31 Dec, 2018 7,898 2,164 1.48
31 Dec, 2017 3,669 1,450 0.21

Announced Financial Year Subject EX Date Payment Date Amount Indicator
24 Dec 2019 31 Dec 2019 First Interim Dividend 02 Jan 2020 17 Jan 2020 0.0020 Currency View
28 Jun 2019 31 Dec 2018 Final Dividend 15 Jul 2019 08 Aug 2019 0.0020 Currency View
12 Dec 2018 31 Dec 2018 First Interim Dividend 26 Dec 2018 18 Jan 2019 0.0040 Currency View

Announced EX Date Subject Ratio
No records

Name Price Change Volume Gearing Premium Premium % Maturity
No warrants found.

Announced Date Change Type Shares Name
No records


Recent News


Recent Announcements
  • MATERIAL LITIGATION
    NOVA PHARMA SOLUTIONS BERHAD ("NPS" OR "THE COMPANY") - Material Litigation Between NPS ("Plaintiff") vs Oriental Mace Sdn. Bhd. ("OMSB") (Defendant)
  • OTHERS
    NOVA PHARMA SOLUTIONS BERHAD (NPS OR THE COMPANY) - Postponement of the Forty-Third Annual General Meeting (43rd AGM)
  • General Meetings: Notice of Meeting
  • MATERIAL LITIGATION
    NOVA PHARMA SOLUTIONS BERHAD ("NPS" OR "THE COMPANY") - Material Litigation Between NPS (Plaintiff) vs Oriental Mace Sdn Bhd (Defendant)
  • Annual Audited Accounts - 31 Dec 2020


Comments
Login to comment.

Kian Sen
Like · Reply
真的没人在这边,哈哈哈
LuQman NaZri
hahaha...damn
Like · 11 months · translate
Syahril
peaceful here. lucky this company only build plant. price maintain for 52 weeks. lol
Like · 11 months · translate
Sk Lee
Like · Reply
做么我买不到这个股的?